Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ONCO
ONCO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ONCO News
Onconetix Approves 1-for-10 Reverse Stock Split
May 20 2026
NASDAQ.COM
Proclarix® Clinical Data Reinforces Performance in Reducing Overdiagnosis
May 13 2026
Newsfilter
REPL Faces Pressure After FDA Issues Second Complete Response Letter
Apr 14 2026
stocktwits
Onconetix Appoints New CEO and Board Member
Mar 31 2026
seekingalpha
What’s Behind the 50% Surge of This Micro-Cap Stock in Premarket Trading?
Mar 27 2026
stocktwits
Onconetix Partners with Realbotix for 6G Trial
Mar 26 2026
NASDAQ.COM
Onconetix Announces 1-for-5 Reverse Stock Split
Mar 23 2026
seekingalpha
Realbotix Enters All-Stock Acquisition Agreement with Onconetix
Feb 12 2026
seekingalpha
ANDREW KIGUEL TO ASSUME CEO ROLE OF MERGED COMPANY AFTER CLOSURE, SAYS ONCONETIX INC.
Feb 12 2026
moomoo
REALBOTIX CORP - ONCONETIX ACQUIRES FULL OWNERSHIP OF REALBOTIX, LLC THROUGH STOCK TRANSACTION
Feb 12 2026
moomoo
ONCONETIX INC - FOLLOWING DEAL CLOSURE, REALBOTIX PARENT WILL ACQUIRE 75% TO 90% OF FULLY DILUTED COMMON SHARES IN THE COMBINED ENTITY
Feb 12 2026
moomoo
ONCONETIX INC TO PURCHASE 100% OF REALBOTIX'S ISSUED AND OUTSTANDING EQUITY INTERESTS THROUGH AN ALL-STOCK DEAL
Feb 12 2026
moomoo
ONCONETIX SET TO PURCHASE REALBOTIX LLC, AN AI-DRIVEN HUMANOID ROBOTICS FIRM BASED IN THE USA
Feb 12 2026
moomoo
Authparency.ai Wins First Prize at Southlake Innovation Cup for Solving Healthcare Authorization Issues
Dec 30 2025
Yahoo Finance
Onconetix Secures $12.9 Million in Financing via Series D Preferred Stock and Warrants, Ends Merger Agreement with Ocuvex, Inc., and Settles $8.8 Million Debt with Veru, Inc.
Sep 26 2025
Newsfilter
Joint Announcement: Onconetix and Ocuvex Declare End of Merger Agreement
Sep 26 2025
Newsfilter
Show More News
